139 related articles for article (PubMed ID: 8877336)
1. Heterogeneity of acute intermittent porphyria: a subtype with normal erythrocyte porphobilinogen deaminase activity in Germany.
Gross U; Honcamp M; Doss MO
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):613-8. PubMed ID: 8877336
[TBL] [Abstract][Full Text] [Related]
2. Haem precursors and porphobilinogen deaminase in erythrocytes and lymphocytes of patients with acute intermittent porphyria.
Gross U; Jacob K; Frank M; Doss MO
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):29-35. PubMed ID: 9074786
[TBL] [Abstract][Full Text] [Related]
3. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
Sardh E; Rejkjaer L; Andersson DE; Harper P
Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984
[TBL] [Abstract][Full Text] [Related]
4. Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.
Hessels J; Voortman G; van der Wagen A; van der Elzen C; Scheffer H; Zuijderhoudt FM
J Inherit Metab Dis; 2004; 27(1):19-27. PubMed ID: 14970743
[TBL] [Abstract][Full Text] [Related]
5. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
Kostrzewska E; Gregor A
Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of acute intermittent porphyria in a Mexican psychiatric population.
Jara-Prado A; Yescas P; Sánchez FJ; Ríos C; Garnica R; Alonso E
Arch Med Res; 2000; 31(4):404-8. PubMed ID: 11068084
[TBL] [Abstract][Full Text] [Related]
7. Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase.
Llewellyn DH; Whatley S; Elder GH
Hum Mol Genet; 1993 Aug; 2(8):1315-6. PubMed ID: 8401516
[No Abstract] [Full Text] [Related]
8. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
[TBL] [Abstract][Full Text] [Related]
9. Acute intermittent porphyria and mental illness--a family study.
Patience DA; Blackwood DH; McColl KE; Moore MR
Acta Psychiatr Scand; 1994 Apr; 89(4):262-7. PubMed ID: 8023693
[TBL] [Abstract][Full Text] [Related]
10. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.
Nordmann Y; Puy H; Da Silva V; Simonin S; Robreau AM; Bonaiti C; Phung LN; Deybach JC
J Intern Med; 1997 Sep; 242(3):213-7. PubMed ID: 9350165
[TBL] [Abstract][Full Text] [Related]
11. Mutations in acute intermittent porphyria detected by ELISA measurement of porphobilinogen deaminase.
Lannfelt L; Wetterberg L; Gellerfors P; Lilius L; Floderus Y; Thunell S
J Clin Chem Clin Biochem; 1989 Nov; 27(11):857-62. PubMed ID: 2607315
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
[TBL] [Abstract][Full Text] [Related]
13. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
Iwanov ED; Adjarov D; Tsanev R
Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
[TBL] [Abstract][Full Text] [Related]
14. Immunological determination of porphobilinogen deaminase as a diagnostic measure in acute intermittent porphyria.
Lannfelt L
J Clin Chem Clin Biochem; 1990 May; 28(5):273-8. PubMed ID: 2380662
[TBL] [Abstract][Full Text] [Related]
15. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria.
Mustajoki P
Ann Intern Med; 1981 Aug; 95(2):162-6. PubMed ID: 7258864
[TBL] [Abstract][Full Text] [Related]
16. [Acute intermittent porphyria and chronic transaminase elevation].
Raigal Martín MY; Lledó Navarro JL; Raigal Martín JM; Muriel Patino E; Pérez Pérez E; Moreno Prat M
Gastroenterol Hepatol; 2008 Apr; 31(4):225-8. PubMed ID: 18405488
[TBL] [Abstract][Full Text] [Related]
17. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland.
Mustajoki P; Kauppinen R; Lannfelt L; Lilius L; Koistinen J
J Intern Med; 1992 Apr; 231(4):389-95. PubMed ID: 1588264
[TBL] [Abstract][Full Text] [Related]
18. Denaturing gradient gel electrophoresis for rapid detection of latent carriers of a subtype of acute intermittent porphyria with normal erythrocyte porphobilinogen deaminase activity.
Bourgeois F; Gu XF; Deybach JC; Te Velde MP; de Rooij F; Nordmann Y; Grandchamp B
Clin Chem; 1992 Jan; 38(1):93-5. PubMed ID: 1733614
[TBL] [Abstract][Full Text] [Related]
19. Variegate porphyria with coexistent decrease in porphobilinogen deaminase activity.
Weinlich G; Doss MO; Sepp N; Fritsch P
Acta Derm Venereol; 2001; 81(5):356-9. PubMed ID: 11800145
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of porphobilinogen (PBG) deaminase gene mutations in acute intermittent porphyria: first study in patients of Slavic origin.
Rosipal R; Puy H; Lamoril J; Martasek P; Nordmann Y; Deybach JC
Scand J Clin Lab Invest; 1997 May; 57(3):217-24. PubMed ID: 9238757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
